1. Home
  2. STAA vs NTLA Comparison

STAA vs NTLA Comparison

Compare STAA & NTLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo STAAR Surgical Company

STAA

STAAR Surgical Company

HOLD

Current Price

$20.87

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Logo Intellia Therapeutics Inc.

NTLA

Intellia Therapeutics Inc.

HOLD

Current Price

$12.52

Market Cap

986.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STAA
NTLA
Founded
1982
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Ophthalmic Goods
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
986.9M
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
STAA
NTLA
Price
$20.87
$12.52
Analyst Decision
Hold
Buy
Analyst Count
10
22
Target Price
$24.56
$19.83
AVG Volume (30 Days)
1.7M
4.4M
Earning Date
02-10-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$230,591,000.00
$57,528,000.00
Revenue This Year
N/A
$1.96
Revenue Next Year
$21.97
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
33.52
52 Week Low
$13.50
$5.90
52 Week High
$30.81
$28.25

Technical Indicators

Market Signals
Indicator
STAA
NTLA
Relative Strength Index (RSI) 35.54 71.95
Support Level $21.00 $11.34
Resistance Level $23.25 $9.62
Average True Range (ATR) 1.06 0.70
MACD -0.14 0.38
Stochastic Oscillator 32.30 93.04

Price Performance

Historical Comparison
STAA
NTLA

About STAA STAAR Surgical Company

Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.

About NTLA Intellia Therapeutics Inc.

Intellia Therapeutics is a gene-editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.

Share on Social Networks: